KIF5B and neoplasm: Administration of 50 mg per kg BID vepafestinib had a significant anti-tumor effect on Ba/F3 KIF5B–RETG810R tumors without any animal body weight changes (Fig. 7d and Extended Data Fig. 8f,g).